can a type 1 diabetic take semaglutide could remove need for insulin injections in diabetes, promising study shows Ozempic lowers total daily insulin

While the FDA prescribing information does not list hepatotoxicity as a recognized adverse effect, understanding the medication's safety profileincluding rare case reports and labeled risks like gallbladder diseasehelps patients and providers make informed treatment decisions

Always consult your healthcare provider for medical guidance.

However, site consistency matters

Clinical Efficacy: Clinical trials (e.g., STEP and SUSTAIN programs) have demonstrated that Semaglutide, at doses up to 2.4 mg weekly, achieves: Weight Loss: Up to 1520% body weight reduction in obese or overweight adults after 68 weeks, when combined with lifestyle changes